Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanylate cyclase-C (GC-C) is a type I transmembrane receptor with intrinsic guanylyl cyclase activity. It is predominantly expressed on the apical surface of intestinal epithelial cells, where it plays a central role in regulating fluid and electrolyte homeostasis in the gastrointestinal tract. Activation of GC-C leads to increased intracellular cGMP levels, which regulate downstream targets involved in ion transport and other cellular processes. GC-C is targeted therapeutically for conditions like chronic idiopathic constipation and irritable bowel syndrome with constipation.
GC-C agonists stimulate cGMP production, leading to increased chloride and bicarbonate secretion and decreased sodium absorption in the intestine, promoting fluid secretion and relieving constipation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanylate cyclase C receptor (GC-C).